By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Janssen Biotech Inc. 

800 Ridgeview Drive

Horsham  Pennsylvania  19044  U.S.A.
Phone: 888-227-5624 Fax: n/a


Company News
Janssen Biotech (JNJ) Submits Application To FDA Seeking Approval Of Anti-Interleukin-23 Monoclonal Antibody Guselkumab For The Treatment Of Moderate To Severe Plaque Psoriasis 11/17/2016 7:01:16 AM
Janssen Biotech (JNJ) Release: Two Studies Reveal Differences In Real-World Treatment Patterns In Rheumatoid Arthritis Patients Taking REMICAD (infliximab) Compared To CT-P13 (infliximab biosimilar) 11/14/2016 9:22:26 AM
Amgen (AMGN) Announces Collaboration With Janssen Biotech (JNJ) To Co-Fund Studies With KYPROLIS (Carfilzomib) And DARZALEX (Daratumumab) In Patients With Multiple Myeloma 11/10/2016 3:27:38 PM
Chengdu's HitGen Collaborates With Janssen Biotech (JNJ) On Oncology And Metabolics Discovery 10/4/2016 8:22:47 AM
Janssen Biotech (JNJ) Release: FDA Approves STELARA (ustekinumab) For Treatment Of Adults With Moderately To Severely Active Crohn's Disease 9/26/2016 8:16:26 AM
Janssen Biotech (JNJ) Submits Application Seeking Approval Of Sirukumab In United States For Rheumatoid Arthritis 9/23/2016 8:29:29 AM
Janssen Biotech (JNJ) Submits Application To U.S. FDA To Expand Indication For Daratumumab (DARZALEX) 8/18/2016 6:47:40 AM
Carna Biosciences Cancels Deal With Janssen Biotech (JNJ) Due to Strategy Reasons 8/5/2016 6:11:35 AM
Janssen Biotech (JNJ) Announces Clinical Collaboration With Bristol-Myers Squibb (BMY) To Evaluate Immuno-Oncology Combination In Lung Cancer 7/26/2016 6:26:16 AM
SoCal's Ionis Pharma (IONS) Cuts GI Deal Worth $810 Million With Janssen Biotech (JNJ) 7/19/2016 5:47:12 AM